查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1637904

美國安瓿包裝：市場佔有率分析、產業趨勢、統計數據、成長預測（2025-2030 年）

United States Ampoules Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計預測期內美國安瓿包裝市場的複合年成長率為 6.82%。

美國安瓿瓶包裝-市場-IMG1

主要亮點

  • 安瓿瓶廣泛用於製藥和化學實驗室，用於儲存和保存藥物溶液、膠囊和液體。這對產品的保存期限有重大影響，因為它可以防止藥品的污染和摻假。玻璃安瓿瓶透明度高，易於檢查內容物，相對不透濕、不透氣，對大多數藥物具有耐化學性，因此具有很強的保護性。
  • 塑膠安瓿瓶推出市場是為了解決安瓿瓶破裂時玻璃顆粒可能進入內容物的擔憂。預計這將為塑膠安瓿製造商創造機會，因為他們可能會受到不同國家監管升級和標準的影響。
  • 為了滿足各個終端用戶產業日益成長的需求，一些公司生產客製化尺寸的玻璃安瓿瓶。直柄安瓿瓶和開口漏斗玻璃安瓿瓶是兩種不同的安瓿瓶。由於疫苗市場的成長，直柄安瓿瓶的需求預計會增加。近期的新冠疫情，為蓬勃發展的疫苗產業的發展提供了進一步的動力。
  • 此外，為了維持藥物特性，玻璃是藥用安瓿瓶市場最常用的首選材料。例如，葉酸鈣等細胞毒藥物通常以 3 mg/ml 注射的形式包裝在 10 ml 安瓿瓶中。安瓿的另一個重要應用領域是化妝品/美容行業。臉部、眼部、頭髮和手部高品質酏劑和精華液的市場不斷成長是市場發展的關鍵促進因素。
  • 然而，玻璃安瓿瓶的製造和運輸成本比塑膠安瓿瓶更高，對使用過的安瓿瓶的不當處理可能會在預測期內阻礙市場的成長。
  • 由於製造延誤造成供應鏈困難，COVID-19 的蔓延對市場產生了負面影響。然而，隨著生產更多的 COVID 疫苗以對抗 COVID-19 的傳播，情況發生了變化，這導致製藥業務對安瓿瓶的需求增加，從而促進了 COVID-19 期間市場的擴張。

美國安瓿瓶包裝市場趨勢

玻璃具有較高的商業價值，因此可回收性高

  • 美國消費者重視永續和環保的包裝解決方案，這就是為什麼製造商選擇玻璃安瓿瓶而不是其他包裝解決方案。 Gerresheimer 等公司服務於國際醫藥和醫療保健行業的所有細分市場，涵蓋美容和衛生的各個方面。
  • 由於大多數包裝解決方案都是基於玻璃的，因此藥品包裝只佔廢棄物的一小部分。玻璃包裝也是100%可回收的，從環保角度來看，它是首選的包裝選擇。此外，有色玻璃（例如琥珀色或紅色）可以保護內容物免受紫外線和某些波長的傷害。玻璃安瓿瓶易於加熱滅菌，適合用於藥品包裝。
  • 此外，政府推出了嚴格的法規，限制 PET 材料在藥品包裝中的使用，這使得玻璃包裝在製藥業更具吸引力。
  • 此外，根據玻璃包裝協會 (GPI) 的說法，使用回收玻璃製造新產品可減少原料消耗、減少排放氣體、延長熔爐等玻璃製造設備的使用壽命並節省能源。例如，在製造過程中每使用10%的回收碎玻璃（玻璃屑），能源成本就會降低約2-3%。
  • 玻璃包裝協會已設立目標並正在製定計劃，到2030年實現美國50%的回收率。然而，美國玻璃容器的回收率僅37%左右，需要迎頭趕上。歐洲已實現約74%的高玻璃回收率。市政當局和材料回收機構正在努力透過認證和試點計畫來提高美國的玻璃回收率。
  • 據 IQVIA 稱，2021 年品牌藥銷售額占美國藥品金額的 84%。 2021年藥品總支出將達到約5,740億美元。 2012年至2021年期間，支出將逐年增加，總合2,550億美元。支出的增加無疑將影響預測期內對安瓿瓶的需求。

製藥業佔很大佔有率

  • 由於疫苗儲存需求的不斷成長，對藥用玻璃安瓿瓶的需求預計會增加。此外，隨著美國居民健康問題的增加，製造業急劇增加以滿足需求。儘管許多公司在新冠疫情期間看到需求受到負面影響，但一些行業卻實現了成長，其中包括製藥玻璃產業。
  • 此外，肖特 (Schott) 和 Gerresheimer AG 等玻璃製造商報告稱，為適應 COVID-19 疫苗相關的發展，製藥業對安瓿瓶、瓶子和管瓶的需求增加。
  • 由於擔心光線和紫外線透過率太高，安瓿瓶在醫藥市場的使用量不斷增加。安瓿可以提供更好的保護和安全，防止受到各種波長的輻射，對於儲存多種藥物至關重要。塑膠安瓿瓶的可塑性刺激了多種形狀和尺寸的安瓿瓶的生產，以滿足製藥業的各種應用。
  • 此外，越來越多的消費者選擇單劑量腸外包裝，而不是多劑量包裝。塑膠安瓿瓶提供固定劑量，有助於製藥公司減少藥物過度填充和製造過程中的其他低效率，從而控制成本。因此，塑膠安瓿瓶對於經營昂貴藥品的製藥公司來說特別有利。
  • 此外，美國主要製藥公司在全球醫藥市場佔有較大的佔有率，2021年美國的佔有率為40.8%就證明了這一點。例如，根據 IQVIA 的數據，2021 年，美國是全球最大的國內醫藥市場，約佔所有醫藥支出的 41%。中國已確立其第二大市場地位，市場佔有率接近12%。

美國安瓿瓶包裝產業概況

由於市場供應商數量較少且該地區的行業已成熟，美國安瓿瓶包裝市場正在整合。市場參與者正在尋找新方法，例如策略夥伴關係和新產品發布，以加速美國安瓿包裝市場的發展。

  • 2022 年 1 月：Ritedose Corporation 宣布計劃開發和商業化 20 年來第一種分配單劑量液體藥物的新方法。經過五年的研究和開發，這家開發了吹灌封單劑量技術的公司推出了SuredoseRx™，這是一種更簡單、更實用的為醫護人員和患者分配單劑量液體藥物的方法。到了。該公司將在 Ritedose Corp. 的非專利液體藥物新單劑量吹灌密封安瓿瓶中推出三種最受歡迎的液體藥物，以降低溢出和污染的風險。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 研究假設和市場定義
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場洞察

  • 市場概況
  • 產業吸引力－波特五力分析
    • 新進入者的威脅
    • 買家的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭對手之間的競爭強度
  • 產業價值鏈分析
  • COVID-19 產業影響評估

第5章 市場動態

  • 市場促進因素
    • 防竄改藥品包裝的需求
    • 提高可回收玻璃的商業價值
  • 市場限制
    • 對傾倒使用過的安瓿瓶的擔憂

第6章 市場細分

  • 按材質
    • 玻璃
    • 塑膠
  • 按最終用戶
    • 藥品
    • 個人護理和化妝品

第7章 競爭格局

  • 公司簡介
    • Schott AG
    • J. Penner Corporation
    • Gerresheimer AG
    • Stevanato Group
    • Accu-Glass, LLC
    • Nipro Pharma Packaging International NV
    • James Alexander Corporation
    • Wheaton Group（DWK Life Sciences, Inc.）

第8章投資分析

第9章：市場的未來

簡介目錄
Product Code: 48413

The United States Ampoules Packaging Market is expected to register a CAGR of 6.82% during the forecast period.

United States Ampoules Packaging - Market - IMG1

Key Highlights

  • Ampoules are widely used in pharmaceutical and chemical laboratories to preserve and store medicinal fluids, capsules, and liquids. They have greatly influenced the shelf life of products as they prevent contamination and mix of medicines. Glass ampoules offer high transparency enabling easy inspection of their contents and higher protection as they are relatively impervious to moisture and air and chemically resistant to most medicinal products.
  • The emergence of plastic ampoules in the market has been to counter some of the concerns relating to glass particles entering the contents during the breaking of the ampoules. This is expected to create an opportunity for plastic ampoules manufacturers and may be impacted by regulatory upgrades and standards in the respective nation.
  • Several players are manufacturing custom-sized glass ampoules to cater to the swelling demand from various end-user industries. Straight stem ampoules and open funnel glass ampoules are manufactured for two different ampoules. Straight-stem ampoules are expected to witness increased demand owing to the growth of the vaccine market. The recent COVID-19 pandemic has provided further impetus to developing the fast-growing vaccine industry.
  • Additionally, to maintain the properties of the medications, glass is a preferred material predominantly used in the pharmaceutical ampoule market. For instance, cytotoxic medicines, such as calcium folinate, are primarily packed in 3 mg/ml injection in the 10ml ampoule. Other significant areas of application for ampoules constitute the cosmetics/beauty industry. The growing market for high-quality elixirs and serum products for the face, eye area, hair, and hands have been a significant driver in the studied market.
  • However, improper disposal of used ampoules will impede market expansion in the projected timeframe as glass ampoules are more expensive to manufacture and ship compared to plastic ones.
  • The spread of COVID-19 negatively impacted the market due to supply chain difficulties brought on by delayed manufacturing. However, the situation drastically changed because more COVID vaccines were produced to counter the spread, which increased the demand for ampoules in the pharmaceutical business, which aided the market expansion during COVID-19.

US Ampoules Packaging Market Trends

High Commodity Value of Glass Resulting in High Recyclability

  • Consumers in the United States are placing greater importance on sustainable, eco-friendly packaging solutions, which allows manufacturers to adopt glass ampoules over alternative packaging solutions. Companies such as Gerresheimer serve all market segments of the international pharmaceutical and healthcare industry, covering all aspects of beauty and hygiene.
  • Pharmaceutical packaging accounts for a small proportion of waste because most of the packaging solutions use glass as a material. Additionally, glass packaging is 100% recyclable, which makes it a desirable packaging option from an environmental point of view. Moreover, colored glass, such as amber and red-colored glass, protects its contents from ultraviolet rays and specific wavelengths. Glass ampoules can easily sterilize using heat, making them suitable for pharmaceutical packaging.
  • Furthermore, strict government regulations regarding the restrictions on the usage of PET material for pharmaceutical packaging further increase the attractiveness of glass packaging for the pharmaceutical industry.
  • Also, according to the Glass Packaging Institute (GPI), using recycled glass in the manufacturing of new products reduces the consumption of raw materials, cuts emissions, extends the life of glass-making equipment such as furnaces, and saves energy. For instance, energy costs are reduced by around 2-3% for every 10% crushed recycled glass (cullet) used in the production process.
  • The Glass Packaging Institute has set a target and plans to achieve a 50% recycling rate in the United States by 2030. However, the United States needs to catch up to the glass recycling rate, with around 37% of container glass being recycled. Europe has achieved a higher glass recycling rate of about 74%. Municipalities and Materials Recovery Facilities are attempting to increase the United States glass recycling rate through certifications and pilot programs.
  • According to IQVIA, sales of brand-name drugs accounted for an 84% share of the money spent on medicines in the United States in 2021. The total amount spent on medicines reached about USD 574 billion in 2021. The spending increased year on year between 2012 and 2021, raising the total by USD 255 billion. The increased spending will undoubtedly impact the demand for ampoules in the projected time.

Pharmaceutical Industry will have a Significant Share

  • Pharmaceutical glass ampoules demand is expected to increase due to the growing need for vaccine storage. Also, owing to the increasing health-related issues among the people living in the United States, manufacturing to meet the demand has increased dramatically. Even though many businesses faced negatively affected demand during the COVID-19 pandemic, few sectors, including the pharmaceutical glass industry, witnessed growth.
  • Additionally, glassmakers such as Schott and Gerresheimer AG have reported increased demand from the pharmaceutical sector for ampoules, bottles, and vials to meet COVID-19 vaccine-related developments.
  • Concerns such as light and ultraviolet penetration led to the growth in the use of ampoules in the pharmaceutical market. Ampoules offer better protection and security from various wavelengths of radiation and are mandatory for storing several medications. The moldable characteristic of plastic ampoules has stimulated ampoule manufacturing in multiple shapes and sizes for different uses in the pharmaceutical sector.
  • Moreover, the choice of unit-dose parenteral packaging for consumers over multi-dose packaging has increased. Plastic ampoules provide fixed dosages to help pharmaceutical companies control costs by reducing drug overfill and other inefficiencies in the production process. Hence, plastic ampoules are especially advantageous for pharmaceutical companies dealing with costly drugs.
  • Furthermore, the leading pharmaceutical companies in the United States hold a significant share of the global pharmaceutical markets, which is evident from the fact that the united states had 40.8% in 2021. For instance, according to IQVIA, In 2021, the United States held the position as the world's largest national pharmaceutical market, accounting for around 41% of all pharmaceutical expenditures. With a nearly 12% market share, China has established itself as the second-largest market.

US Ampoules Packaging Industry Overview

The United States Ampoules Packaging Market is consolidated due to the presence of few vendors in the market and the maturity status of the industry in the region. The market players are finding new ways, such as strategic partnerships or launching new products, to accelerate the development of ampoule packaging in the United States.

  • January 2022: The Ritedose Corporation announced the development of and planned to commercialize the first new way to dispense single-dose liquid medications in two decades. After five years of research and development, the blow-fill-seal unit dosage technology creator introduced SuredoseRxTM, a simpler and more practical method for healthcare professionals to dispense and for patients to consume single doses of liquid drugs. The company is debuting three of its most popular liquid drugs in a new, single-dose, blow-fill-seal ampoule for generic liquid medications from Ritedose Corp. to reduce the risk of spills and contamination.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of COVID-19 on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Demand for Tamper-proof Pharmaceutical Product Packaging
    • 5.1.2 Commodity Value of Glass Increased with Recyclability
  • 5.2 Market Restraints
    • 5.2.1 Concerns Regarding Dumping of Used Ampoules

6 MARKET SEGMENTATION

  • 6.1 By Material
    • 6.1.1 Glass
    • 6.1.2 Plastics
  • 6.2 By End-user
    • 6.2.1 Pharmaceutical
    • 6.2.2 Personal Care and Cosmetic

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Schott AG
    • 7.1.2 J. Penner Corporation
    • 7.1.3 Gerresheimer AG
    • 7.1.4 Stevanato Group
    • 7.1.5 Accu-Glass, LLC
    • 7.1.6 Nipro Pharma Packaging International NV
    • 7.1.7 James Alexander Corporation
    • 7.1.8 Wheaton Group (DWK Life Sciences, Inc.)

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET